Twist Stock Financials


USD 39.26  3.18  8.81%   

Financial data analysis helps to confirm if markets are presently mispricing Twist Bioscience. We are able to interpolate and collect thirty available drivers for Twist Bioscience Corp, which can be compared to its competition. To ensure the equity is not overpriced, please validate all Twist Bioscience financials, including its revenue, as well as the relationship between the total debt and earnings per share . Given that Twist Bioscience Corp has a shares owned by institutions of 106.62 %, we advise you to double-check Twist Bioscience Corp current market performance to make sure the company can sustain itself down the road. Use Twist Bioscience to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of Twist Bioscience to be traded at $49.08 in 90 days.
With this module, you can analyze Twist financials for your investing period. You should be able to track the changes in Twist Bioscience individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Twist Bioscience Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Twist Bioscience's financial statements are interrelated, with each one affecting the others. For example, an increase in Twist Bioscience's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 24
Twist Bioscience Corp has less than 24 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Twist Bioscience stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Twist Bioscience's official financial statements usually reflect Twist Bioscience's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Twist Bioscience Corp. For example, before you start analyzing numbers published by Twist accountants, it's critical to develop an understanding of what Twist Bioscience's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Twist Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Twist Bioscience's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Twist Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Twist Bioscience Corp. Please utilize our Beneish M Score to check the likelihood of Twist Bioscience's management to manipulate its earnings.

Twist Bioscience Company Summary

Twist Bioscience competes with Amazon. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California. Twist Bioscience operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 652 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address681 Gateway Boulevard
IndustryDiagnostics & Research
Phone800 719 0671
CurrencyUSD - US Dollar
You should never invest in Twist Bioscience without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Twist Stock, because this is throwing your money away. Analyzing the key information contained in Twist Bioscience's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Twist Bioscience Key Financial Ratios

Generally speaking, Twist Bioscience's financial ratios allow both analysts and investors to convert raw data from Twist Bioscience's financial statements into concise, actionable information that can be used to evaluate the performance of Twist Bioscience over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Twist Bioscience Corp reports annually and quarterly.

Twist Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Twist Bioscience's current stock value. Our valuation model uses many indicators to compare Twist Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Twist Bioscience competition to find correlations between indicators driving Twist Bioscience's intrinsic value. More Info.
Twist Bioscience Corp is currently regarded number one company in revenue category among related companies. It is currently regarded as top stock in z score category among related companies . The ratio of Revenue to Z Score for Twist Bioscience Corp is about  12,945,238 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Twist Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Twist Bioscience's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Twist Bioscience's earnings, one of the primary drivers of an investment's value.

Twist Bioscience Corp Systematic Risk

Twist Bioscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Twist Bioscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Twist Bioscience Corp correlated with the market. If Beta is less than 0 Twist Bioscience generally moves in the opposite direction as compared to the market. If Twist Bioscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Twist Bioscience Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Twist Bioscience is generally in the same direction as the market. If Beta > 1 Twist Bioscience moves generally in the same direction as, but more than the movement of the benchmark.

About Twist Bioscience Financials

What exactly are Twist Bioscience Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Twist Bioscience's income statement, its balance sheet, and the statement of cash flows. Potential Twist Bioscience investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may use each financial statement separately, they are all related. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Twist Bioscience's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Twist Bioscience is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Twist has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Twist Bioscience October 4, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Twist Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Twist Bioscience Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Twist Bioscience Corp based on widely used predictive technical indicators. In general, we focus on analyzing Twist Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Twist Bioscience's daily price indicators and compare them against related drivers.
Downside Deviation5.98
Information Ratio0.0467
Maximum Drawdown26.88
Value At Risk(8.84)
Potential Upside8.47
Additionally, take a look at World Market Map. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for analysis

When running Twist Bioscience Corp price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Is Twist Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Twist Bioscience. If investors know Twist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Twist Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Twist Bioscience Corp is measured differently than its book value, which is the value of Twist that is recorded on the company's balance sheet. Investors also form their own opinion of Twist Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Twist Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Twist Bioscience's market value can be influenced by many factors that don't directly affect Twist Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine Twist Bioscience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.